Global Sacral Neuromodulation System Market Insights, Forecast to 2029

Sacral Neuromodulation System Market

Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities.

Market Analysis and Insights: Global Sacral Neuromodulation System Market

The global Sacral Neuromodulation System market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sacral Neuromodulation System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Sacral Neuromodulation System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Sacral Neuromodulation System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Sacral Neuromodulation System include Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), Neurosigma, Inc. (US), Neuropace, Inc. (US), Neuronetics, Inc. (US) and Cyberonics, Inc. (US), etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Sacral Neuromodulation System market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Sacral Neuromodulation System, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sacral Neuromodulation System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sacral Neuromodulation System revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Sacral Neuromodulation System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Sacral Neuromodulation System revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), Neurosigma, Inc. (US), Neuropace, Inc. (US), Neuronetics, Inc. (US) and Cyberonics, Inc. (US), etc.

Scope of Sacral Neuromodulation System Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sacral Neuromodulation System Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Internal Neuromodulation System

1.2.3 External Neuromodulation System

1.3 Market by Application

1.3.1 Global Sacral Neuromodulation System Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Spinal Cord Stimulation

1.3.3 Deep Brain Stimulation

1.3.4 Sacral Nerve Stimulation

1.3.5 Vagus Nerve Stimulation

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Sacral Neuromodulation System Market Perspective (2018-2029)

2.2 Global Sacral Neuromodulation System Growth Trends by Region

2.2.1 Sacral Neuromodulation System Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Sacral Neuromodulation System Historic Market Size by Region (2018-2023)

2.2.3 Sacral Neuromodulation System Forecasted Market Size by Region (2024-2029)

2.3 Sacral Neuromodulation System Market Dynamics

2.3.1 Sacral Neuromodulation System Industry Trends

2.3.2 Sacral Neuromodulation System Market Drivers

2.3.3 Sacral Neuromodulation System Market Challenges

2.3.4 Sacral Neuromodulation System Market Restraints

3.1 Global Revenue Sacral Neuromodulation System by Players

3.1.1 Global Sacral Neuromodulation System Revenue by Players (2018-2023)

3.1.2 Global Sacral Neuromodulation System Revenue Market Share by Players (2018-2023)

3.2 Global Sacral Neuromodulation System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Sacral Neuromodulation System, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Sacral Neuromodulation System Market Concentration Ratio

3.4.1 Global Sacral Neuromodulation System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sacral Neuromodulation System Revenue in 2022

3.5 Global Key Players of Sacral Neuromodulation System Head office and Area Served

3.6 Global Key Players of Sacral Neuromodulation System, Product and Application

3.7 Global Key Players of Sacral Neuromodulation System, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Sacral Neuromodulation System Historic Market Size by Type (2018-2023)

4.2 Global Sacral Neuromodulation System Forecasted Market Size by Type (2024-2029)

5.1 Global Sacral Neuromodulation System Historic Market Size by Application (2018-2023)

5.2 Global Sacral Neuromodulation System Forecasted Market Size by Application (2024-2029)

6.1 North America Sacral Neuromodulation System Market Size (2018-2029)

6.2 North America Sacral Neuromodulation System Market Size by Type

6.2.1 North America Sacral Neuromodulation System Market Size by Type (2018-2023)

6.2.2 North America Sacral Neuromodulation System Market Size by Type (2024-2029)

6.2.3 North America Sacral Neuromodulation System Market Share by Type (2018-2029)

6.3 North America Sacral Neuromodulation System Market Size by Application

6.3.1 North America Sacral Neuromodulation System Market Size by Application (2018-2023)

6.3.2 North America Sacral Neuromodulation System Market Size by Application (2024-2029)

6.3.3 North America Sacral Neuromodulation System Market Share by Application (2018-2029)

6.4 North America Sacral Neuromodulation System Market Size by Country

6.4.1 North America Sacral Neuromodulation System Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Sacral Neuromodulation System Market Size by Country (2018-2023)

6.4.3 North America Sacral Neuromodulation System Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7.1 Europe Sacral Neuromodulation System Market Size (2018-2029)

7.2 Europe Sacral Neuromodulation System Market Size by Type

7.2.1 Europe Sacral Neuromodulation System Market Size by Type (2018-2023)

7.2.2 Europe Sacral Neuromodulation System Market Size by Type (2024-2029)

7.2.3 Europe Sacral Neuromodulation System Market Share by Type (2018-2029)

7.3 Europe Sacral Neuromodulation System Market Size by Application

7.3.1 Europe Sacral Neuromodulation System Market Size by Application (2018-2023)

7.3.2 Europe Sacral Neuromodulation System Market Size by Application (2024-2029)

7.3.3 Europe Sacral Neuromodulation System Market Share by Application (2018-2029)

7.4 Europe Sacral Neuromodulation System Market Size by Country

7.4.1 Europe Sacral Neuromodulation System Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Sacral Neuromodulation System Market Size by Country (2018-2023)

7.4.3 Europe Sacral Neuromodulation System Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 China Sacral Neuromodulation System Market Size (2018-2029)

8.2 China Sacral Neuromodulation System Market Size by Type

8.2.1 China Sacral Neuromodulation System Market Size by Type (2018-2023)

8.2.2 China Sacral Neuromodulation System Market Size by Type (2024-2029)

8.2.3 China Sacral Neuromodulation System Market Share by Type (2018-2029)

8.3 China Sacral Neuromodulation System Market Size by Application

8.3.1 China Sacral Neuromodulation System Market Size by Application (2018-2023)

8.3.2 China Sacral Neuromodulation System Market Size by Application (2024-2029)

8.3.3 China Sacral Neuromodulation System Market Share by Application (2018-2029)

9.1 Asia Sacral Neuromodulation System Market Size (2018-2029)

9.2 Asia Sacral Neuromodulation System Market Size by Type

9.2.1 Asia Sacral Neuromodulation System Market Size by Type (2018-2023)

9.2.2 Asia Sacral Neuromodulation System Market Size by Type (2024-2029)

9.2.3 Asia Sacral Neuromodulation System Market Share by Type (2018-2029)

9.3 Asia Sacral Neuromodulation System Market Size by Application

9.3.1 Asia Sacral Neuromodulation System Market Size by Application (2018-2023)

9.3.2 Asia Sacral Neuromodulation System Market Size by Application (2024-2029)

9.3.3 Asia Sacral Neuromodulation System Market Share by Application (2018-2029)

9.4 Asia Sacral Neuromodulation System Market Size by Region

9.4.1 Asia Sacral Neuromodulation System Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Sacral Neuromodulation System Market Size by Region (2018-2023)

9.4.3 Asia Sacral Neuromodulation System Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10.1 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Type

10.2.1 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Application

10.3.1 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Country

10.4.1 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11.1 Medtronic, Inc. (US)

11.1.1 Medtronic, Inc. (US) Company Details

11.1.2 Medtronic, Inc. (US) Business Overview

11.1.3 Medtronic, Inc. (US) Sacral Neuromodulation System Introduction

11.1.4 Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023)

11.1.5 Medtronic, Inc. (US) Recent Developments

11.2 Boston Scientific Corporation (US)

11.2.1 Boston Scientific Corporation (US) Company Details

11.2.2 Boston Scientific Corporation (US) Business Overview

11.2.3 Boston Scientific Corporation (US) Sacral Neuromodulation System Introduction

11.2.4 Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2018-2023)

11.2.5 Boston Scientific Corporation (US) Recent Developments

11.3 St. Jude Medical, Inc. (US)

11.3.1 St. Jude Medical, Inc. (US) Company Details

11.3.2 St. Jude Medical, Inc. (US) Business Overview

11.3.3 St. Jude Medical, Inc. (US) Sacral Neuromodulation System Introduction

11.3.4 St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023)

11.3.5 St. Jude Medical, Inc. (US) Recent Developments

11.4 Synapse Biomedical, Inc. (US)

11.4.1 Synapse Biomedical, Inc. (US) Company Details

11.4.2 Synapse Biomedical, Inc. (US) Business Overview

11.4.3 Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Introduction

11.4.4 Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023)

11.4.5 Synapse Biomedical, Inc. (US) Recent Developments

11.5 Nevro Corporation (US)

11.5.1 Nevro Corporation (US) Company Details

11.5.2 Nevro Corporation (US) Business Overview

11.5.3 Nevro Corporation (US) Sacral Neuromodulation System Introduction

11.5.4 Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2018-2023)

11.5.5 Nevro Corporation (US) Recent Developments

11.6 Neurosigma, Inc. (US)

11.6.1 Neurosigma, Inc. (US) Company Details

11.6.2 Neurosigma, Inc. (US) Business Overview

11.6.3 Neurosigma, Inc. (US) Sacral Neuromodulation System Introduction

11.6.4 Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023)

11.6.5 Neurosigma, Inc. (US) Recent Developments

11.7 Neuropace, Inc. (US)

11.7.1 Neuropace, Inc. (US) Company Details

11.7.2 Neuropace, Inc. (US) Business Overview

11.7.3 Neuropace, Inc. (US) Sacral Neuromodulation System Introduction

11.7.4 Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023)

11.7.5 Neuropace, Inc. (US) Recent Developments

11.8 Neuronetics, Inc. (US)

11.8.1 Neuronetics, Inc. (US) Company Details

11.8.2 Neuronetics, Inc. (US) Business Overview

11.8.3 Neuronetics, Inc. (US) Sacral Neuromodulation System Introduction

11.8.4 Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023)

11.8.5 Neuronetics, Inc. (US) Recent Developments

11.9 Cyberonics, Inc. (US)

11.9.1 Cyberonics, Inc. (US) Company Details

11.9.2 Cyberonics, Inc. (US) Business Overview

11.9.3 Cyberonics, Inc. (US) Sacral Neuromodulation System Introduction

11.9.4 Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023)

11.9.5 Cyberonics, Inc. (US) Recent Developments

11.10 BioControl Medical (Israel)

11.10.1 BioControl Medical (Israel) Company Details

11.10.2 BioControl Medical (Israel) Business Overview

11.10.3 BioControl Medical (Israel) Sacral Neuromodulation System Introduction

11.10.4 BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2018-2023)

11.10.5 BioControl Medical (Israel) Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Sacral Neuromodulation System Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

    Table 2. Key Players of Internal Neuromodulation System

    Table 3. Key Players of External Neuromodulation System

    Table 4. Global Sacral Neuromodulation System Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

    Table 5. Global Sacral Neuromodulation System Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Sacral Neuromodulation System Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Sacral Neuromodulation System Market Share by Region (2018-2023)

    Table 8. Global Sacral Neuromodulation System Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Sacral Neuromodulation System Market Share by Region (2024-2029)

    Table 10. Sacral Neuromodulation System Market Trends

    Table 11. Sacral Neuromodulation System Market Drivers

    Table 12. Sacral Neuromodulation System Market Challenges

    Table 13. Sacral Neuromodulation System Market Restraints

    Table 14. Global Sacral Neuromodulation System Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Sacral Neuromodulation System Revenue Share by Players (2018-2023)

    Table 16. Global Top Sacral Neuromodulation System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sacral Neuromodulation System as of 2022)

    Table 17. Global Sacral Neuromodulation System Industry Ranking 2021 VS 2022 VS 2023

    Table 18. Global 5 Largest Players Market Share by Sacral Neuromodulation System Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Global Key Players of Sacral Neuromodulation System, Headquarters and Area Served

    Table 20. Global Key Players of Sacral Neuromodulation System, Product and Application

    Table 21. Global Key Players of Sacral Neuromodulation System, Product and Application

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Sacral Neuromodulation System Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Sacral Neuromodulation System Revenue Market Share by Type (2018-2023)

    Table 25. Global Sacral Neuromodulation System Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Sacral Neuromodulation System Revenue Market Share by Type (2024-2029)

    Table 27. Global Sacral Neuromodulation System Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Sacral Neuromodulation System Revenue Share by Application (2018-2023)

    Table 29. Global Sacral Neuromodulation System Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Sacral Neuromodulation System Revenue Share by Application (2024-2029)

    Table 31. North America Sacral Neuromodulation System Market Size by Type (2018-2023) & (US$ Million)

    Table 32. North America Sacral Neuromodulation System Market Size by Type (2024-2029) & (US$ Million)

    Table 33. North America Sacral Neuromodulation System Market Size by Application (2018-2023) & (US$ Million)

    Table 34. North America Sacral Neuromodulation System Market Size by Application (2024-2029) & (US$ Million)

    Table 35. North America Sacral Neuromodulation System Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. North America Sacral Neuromodulation System Market Size by Country (2018-2023) & (US$ Million)

    Table 37. North America Sacral Neuromodulation System Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Europe Sacral Neuromodulation System Market Size by Type (2018-2023) & (US$ Million)

    Table 39. Europe Sacral Neuromodulation System Market Size by Type (2024-2029) & (US$ Million)

    Table 40. Europe Sacral Neuromodulation System Market Size by Application (2018-2023) & (US$ Million)

    Table 41. Europe Sacral Neuromodulation System Market Size by Application (2024-2029) & (US$ Million)

    Table 42. Europe Sacral Neuromodulation System Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Europe Sacral Neuromodulation System Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Europe Sacral Neuromodulation System Market Size by Country (2024-2029) & (US$ Million)

    Table 45. China Sacral Neuromodulation System Market Size by Type (2018-2023) & (US$ Million)

    Table 46. China Sacral Neuromodulation System Market Size by Type (2024-2029) & (US$ Million)

    Table 47. China Sacral Neuromodulation System Market Size by Application (2018-2023) & (US$ Million)

    Table 48. China Sacral Neuromodulation System Market Size by Application (2024-2029) & (US$ Million)

    Table 49. Asia Sacral Neuromodulation System Market Size by Type (2018-2023) & (US$ Million)

    Table 50. Asia Sacral Neuromodulation System Market Size by Type (2024-2029) & (US$ Million)

    Table 51. Asia Sacral Neuromodulation System Market Size by Application (2018-2023) & (US$ Million)

    Table 52. Asia Sacral Neuromodulation System Market Size by Application (2024-2029) & (US$ Million)

    Table 53. Asia Sacral Neuromodulation System Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 54. Asia Sacral Neuromodulation System Market Size by Region (2018-2023) & (US$ Million)

    Table 55. Asia Sacral Neuromodulation System Market Size by Region (2024-2029) & (US$ Million)

    Table 56. Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Type (2018-2023) & (US$ Million)

    Table 57. Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Type (2024-2029) & (US$ Million)

    Table 58. Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Application (2018-2023) & (US$ Million)

    Table 59. Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Application (2024-2029) & (US$ Million)

    Table 60. Middle East, Africa, and Latin America Sacral Neuromodulation System Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 61. Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Country (2018-2023) & (US$ Million)

    Table 62. Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size by Country (2024-2029) & (US$ Million)

    Table 63. Medtronic, Inc. (US) Company Details

    Table 64. Medtronic, Inc. (US) Business Overview

    Table 65. Medtronic, Inc. (US) Sacral Neuromodulation System Product

    Table 66. Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023) & (US$ Million)

    Table 67. Medtronic, Inc. (US) Recent Developments

    Table 68. Boston Scientific Corporation (US) Company Details

    Table 69. Boston Scientific Corporation (US) Business Overview

    Table 70. Boston Scientific Corporation (US) Sacral Neuromodulation System Product

    Table 71. Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2018-2023) & (US$ Million)

    Table 72. Boston Scientific Corporation (US) Recent Developments

    Table 73. St. Jude Medical, Inc. (US) Company Details

    Table 74. St. Jude Medical, Inc. (US) Business Overview

    Table 75. St. Jude Medical, Inc. (US) Sacral Neuromodulation System Product

    Table 76. St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023) & (US$ Million)

    Table 77. St. Jude Medical, Inc. (US) Recent Developments

    Table 78. Synapse Biomedical, Inc. (US) Company Details

    Table 79. Synapse Biomedical, Inc. (US) Business Overview

    Table 80. Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Product

    Table 81. Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023) & (US$ Million)

    Table 82. Synapse Biomedical, Inc. (US) Recent Developments

    Table 83. Nevro Corporation (US) Company Details

    Table 84. Nevro Corporation (US) Business Overview

    Table 85. Nevro Corporation (US) Sacral Neuromodulation System Product

    Table 86. Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2018-2023) & (US$ Million)

    Table 87. Nevro Corporation (US) Recent Developments

    Table 88. Neurosigma, Inc. (US) Company Details

    Table 89. Neurosigma, Inc. (US) Business Overview

    Table 90. Neurosigma, Inc. (US) Sacral Neuromodulation System Product

    Table 91. Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023) & (US$ Million)

    Table 92. Neurosigma, Inc. (US) Recent Developments

    Table 93. Neuropace, Inc. (US) Company Details

    Table 94. Neuropace, Inc. (US) Business Overview

    Table 95. Neuropace, Inc. (US) Sacral Neuromodulation System Product

    Table 96. Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023) & (US$ Million)

    Table 97. Neuropace, Inc. (US) Recent Developments

    Table 98. Neuronetics, Inc. (US) Company Details

    Table 99. Neuronetics, Inc. (US) Business Overview

    Table 100. Neuronetics, Inc. (US) Sacral Neuromodulation System Product

    Table 101. Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023) & (US$ Million)

    Table 102. Neuronetics, Inc. (US) Recent Developments

    Table 103. Cyberonics, Inc. (US) Company Details

    Table 104. Cyberonics, Inc. (US) Business Overview

    Table 105. Cyberonics, Inc. (US) Sacral Neuromodulation System Product

    Table 106. Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2018-2023) & (US$ Million)

    Table 107. Cyberonics, Inc. (US) Recent Developments

    Table 108. BioControl Medical (Israel) Company Details

    Table 109. BioControl Medical (Israel) Business Overview

    Table 110. BioControl Medical (Israel) Sacral Neuromodulation System Product

    Table 111. BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2018-2023) & (US$ Million)

    Table 112. BioControl Medical (Israel) Recent Developments

    Table 113. Research Programs/Design for This Report

    Table 114. Key Data Information from Secondary Sources

    Table 115. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Sacral Neuromodulation System Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 2. Global Sacral Neuromodulation System Market Share by Type: 2022 VS 2029

    Figure 3. Internal Neuromodulation System Features

    Figure 4. External Neuromodulation System Features

    Figure 5. Global Sacral Neuromodulation System Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 6. Global Sacral Neuromodulation System Market Share by Application: 2022 VS 2029

    Figure 7. Spinal Cord Stimulation Case Studies

    Figure 8. Deep Brain Stimulation Case Studies

    Figure 9. Sacral Nerve Stimulation Case Studies

    Figure 10. Vagus Nerve Stimulation Case Studies

    Figure 11. Sacral Neuromodulation System Report Years Considered

    Figure 12. Global Sacral Neuromodulation System Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Sacral Neuromodulation System Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Sacral Neuromodulation System Market Share by Region: 2022 VS 2029

    Figure 15. Global Sacral Neuromodulation System Market Share by Players in 2022

    Figure 16. Global Top Sacral Neuromodulation System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sacral Neuromodulation System as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Sacral Neuromodulation System Revenue in 2022

    Figure 18. North America Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Sacral Neuromodulation System Market Share by Type (2018-2029)

    Figure 20. North America Sacral Neuromodulation System Market Share by Application (2018-2029)

    Figure 21. North America Sacral Neuromodulation System Market Share by Country (2018-2029)

    Figure 22. United States Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Sacral Neuromodulation System Market Size YoY (2018-2029) & (US$ Million)

    Figure 25. Europe Sacral Neuromodulation System Market Share by Type (2018-2029)

    Figure 26. Europe Sacral Neuromodulation System Market Share by Application (2018-2029)

    Figure 27. Europe Sacral Neuromodulation System Market Share by Country (2018-2029)

    Figure 28. Germany Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. France Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. U.K. Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Italy Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Russia Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Nordic Countries Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. China Sacral Neuromodulation System Market Size YoY (2018-2029) & (US$ Million)

    Figure 35. China Sacral Neuromodulation System Market Share by Type (2018-2029)

    Figure 36. China Sacral Neuromodulation System Market Share by Application (2018-2029)

    Figure 37. Asia Sacral Neuromodulation System Market Size YoY (2018-2029) & (US$ Million)

    Figure 38. Asia Sacral Neuromodulation System Market Share by Type (2018-2029)

    Figure 39. Asia Sacral Neuromodulation System Market Share by Application (2018-2029)

    Figure 40. Asia Sacral Neuromodulation System Market Share by Region (2018-2029)

    Figure 41. Japan Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. South Korea Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. China Taiwan Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Southeast Asia Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. India Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Australia Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East, Africa, and Latin America Sacral Neuromodulation System Market Size YoY (2018-2029) & (US$ Million)

    Figure 48. Middle East, Africa, and Latin America Sacral Neuromodulation System Market Share by Type (2018-2029)

    Figure 49. Middle East, Africa, and Latin America Sacral Neuromodulation System Market Share by Application (2018-2029)

    Figure 50. Middle East, Africa, and Latin America Sacral Neuromodulation System Market Share by Country (2018-2029)

    Figure 51. Brazil Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 52. Mexico Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 53. Turkey Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 54. Saudi Arabia Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 55. Israel Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 56. GCC Countries Sacral Neuromodulation System Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 57. Medtronic, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2018-2023)

    Figure 58. Boston Scientific Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2018-2023)

    Figure 59. St. Jude Medical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2018-2023)

    Figure 60. Synapse Biomedical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2018-2023)

    Figure 61. Nevro Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2018-2023)

    Figure 62. Neurosigma, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2018-2023)

    Figure 63. Neuropace, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2018-2023)

    Figure 64. Neuronetics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2018-2023)

    Figure 65. Cyberonics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2018-2023)

    Figure 66. BioControl Medical (Israel) Revenue Growth Rate in Sacral Neuromodulation System Business (2018-2023)

    Figure 67. Bottom-up and Top-down Approaches for This Report

    Figure 68. Data Triangulation

    Figure 69. Key Executives Interviewed